AVXL
Anavex Life Sciences·NASDAQ
--
--(--)
--
--(--)
7.95 / 10
Outperform
Liquidity flow evaluation: 7.33/10 demonstrating robust fund flow characteristics. Optimistic no significant trends patterns are mitigated by pessimistic overall, block, Small, Medium, Large, and Extra-large indicators, pointing to positive flow perspective. Analyst coverage indicates overwhelmingly bullish analyst consensus with strong conviction. Rating distribution: Strong Buy(100.0%) among 3 analysts, supported by 8.57 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-06
InstitutionD. Boral Capital
Times predicted14
Historical Win Rate57.1%
What is the analyst consensus for AVXL?
- AVXL holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.95/10 (Outperform).
